Owlet, Inc.
NYSE•OWLT
CEO: Mr. Kurt Workman
Sector: Healthcare
Industry: Medical - Devices
Listing Date: 2020-11-05
Owlet, Inc. provides digital parenting solutions in the United States and internationally. The company's platform focuses on giving real-time data and insights to parents. It offers Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology to track vitals signs, such as pulse rate, activity, oxygen, and sleep patterns; BabySat which is intended for infants with heightened health risk; Owlet Cam, a monitoring device in smartphones that offers video and audio, predictive sleep insights, and cry detections; and accessories, including Owlet Sleeper, as well as Duo and Dream Duo that combines Smart Sock with the Owlet Cam. The company was founded in 2012 and is headquartered in Lehi, Utah.
Contact Information
Market Cap
$96.81M
P/E (TTM)
-78.4
33.3
Dividend Yield
--
52W High
$16.94
52W Low
$2.75
52W Range
Rank63Top 94.0%
1.8
F-Score
Modified Piotroski Analysis
Based on 6-year fundamentals
Weak • 1.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2020-2025
Financial Dashboard
Q4 2025 Data
Revenue
$26.50M+0.00%
4-Quarter Trend
EPS
-$0.15+0.00%
4-Quarter Trend
FCF
-$670.00K+0.00%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Revenue Growth Strong Revenues reached $105.71M in 2025, reflecting 35.4% growth compared to prior year sales figures.
Positive Adjusted EBITDA Achieved Adjusted EBITDA turned positive at $1.97M in 2025, improving significantly from a $1.84M loss in 2024.
Operating Loss Narrows Operating loss reduced to $8.26M in 2025 from $20.22M in 2024 due to revenue gains and cost control.
Subscription Service Scaling Owlet360 subscription service rapidly scaled, exceeding 98,000 subscribers by the end of fiscal year 2025.
Risk Factors
Sustained Profitability Risk Incurred $39.68M net loss in 2025; failure to achieve sustained profitability could affect financing ability.
Internal Control Weaknesses Identified material weaknesses in internal control over financial reporting, requiring ongoing remediation efforts and costs.
Supply Chain Concentration Risk Reliance on single-source manufacturers and NAND flash shortages expose margins and product availability to volatility.
App Store Distribution Reliance Products rely on Apple App Store and Google Play Store for distribution; adverse policy changes could severely impact sales.
Outlook
Drive Domestic International Growth Strategy focuses on driving US adoption of Dream Sock and expanding global footprint, targeting India launch in 2026.
Grow Healthcare Reimbursement Expanding BabySat into healthcare channels, securing Medicaid coverage in 37 states and 250 commercial carriers.
Invest AI Platform Capabilities Continued investment in AI integration for camera products and leveraging pediatric data for personalized subscription enhancements.
Peer Comparison
Revenue (TTM)
$112.82M
$105.66M
$77.36M
Gross Margin (Latest Quarter)
100.0%
92.4%
87.3%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| ANIK | $203.48M | -18.5 | -7.4% | 12.7% |
| ELTX | $201.58M | -4.5 | -977.7% | 19.7% |
| SGHT | $199.28M | -5.1 | -55.7% | 35.4% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
7.9%
Steady Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
0%
Cash Flow Needs Attention
Deep Research
Next earnings:May 6, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data